Transplantation of neural stem/progenitor cells (NSPCs) is a promising strategy for repair of the diseased/ injured central nervous system (CNS); however, controlling their differentiation remains a signifi cant hurdle. This study is aimed at controlling differentiation and specifi cally at screening exogenous factors to direct NSPC differentiation into neurons in vitro. In this study, adult rat SVZ-derived NSPCs were treated with several factors and screened individually and in combination for changes in cellular morphology, neuronal marker expression, quantitative real-time qRT-PCR, and electrophysiological properties. These in vitro screens showed that of all the different treatments, dibutyryl cyclic AMP (dbcAMP) and interferon-gamma (IFN-γ) enhanced neuronal differentiation most signifi cantly compared to the 1% fetal bovine serum (FBS) controls. Importantly, the combined treatment of NSPCs with dbcAMP and IFN-γ promoted greater neuronal differentiation as refl ected by an increase in β-III tubulin expression and morphological differentiation. Interestingly, the neurons that were generated from the NSPCs in vitro in the presence of dbcAMP and IFN-γ, alone or in combination, responded to exogenous glutamate (Glu), but not gamma-aminobutyric acid (GABA), indicating that these neurons express glutamate receptors. These NSPC-derived neurons may be promising for neural regenerative strategies in the CNS.
Introduction
N eural stem/progenitor cells (NSPCs) reside in the subependyma of the lateral ventricles in the adult mammalian forebrain [1, 2] and exhibit the cardinal properties of stem cells: self-renewal and multipotentiality (the capability to generate neuronal and glial cells) [1] [2] [3] [4] . They are expanded in vitro under epidermal growth factor (EGF) and basic fi broblast growth factor (bFGF) stimulation as free-fl oating aggregates or neurospheres [1] . These in vitro-expanded NSPCs have attracted great interest as a potential source for replacing neurons that degenerate as a consequence of neurodegenerative diseases/disorders including Alzheimer's, Parkinson's, stroke, and spinal cord injury (SCI). However, the therapeutic potential of these cells is limited by the lack of effective methodologies for controlling their in vitro and in vivo differentiation such that the desired cell types can be generated in large numbers [5, 6] .
A central focus of neural stem cell research is the identifi cation of extrinsic cues and underlying signaling pathways involved in cell fate determination. Recent studies have shown that in vitro differentiation of NSPC progeny into neural phenotypes can be controlled by manipulating their microenvironment, that is, by the addition of growth factors and small molecules to the culture media [7] [8] [9] [10] and/or the use of different substrates including extracellular matrix (ECM) proteins/ligands [11, 12] . The present study focuses on in vitro screening of a number of growth factors and small molecules to guide the selection of potential candidates that direct NSPC differentiation into neurons. The rationale behind screening for neurogenic agents to generate neurons is based on the results of several in vivo studies where transplanted NSPCs differentiated primarily into glial lineages suggesting that the diseased/injured central nervous system (CNS) may be inhibitory to neuronal differentiation of rats as previously described [19] . NSPC neurospheres (passage 4 cultures) were mechanically dissociated into a single cell suspension and seeded onto poly-d-lysine (PDL) (Sigma-Aldrich, St. Louis, MO)/laminin (Gibco-Invitrogen, Burlington, ON, Canada)-coated glass coverslips or tissue culture plates at a cell density of 35,000 cells/cm 2 directly in differentiation media containing 1 of the following in the absence of mitogens: BDNF (100 ng/mL; PeproTech Inc., Rocky Hills, NJ), dbcAMP (4 mM; Sigma-Aldrich), rat IFN-γ (100 ng/mL; PeproTech Inc.), NGF (50 ng/mL; PeproTech Inc.), NT3 (20 ng/mL; PeproTech Inc.), all-trans RA (100 or 500 nM; Sigma-Aldrich), Shh (1 μg/mL; R&D Systems, Minneapolis, MN), or 1% FBS (Gibco-Invitrogen) as a control. The medium was changed every 3 days. In subsequent experiments, cells were "primed" (incubated) in complete media containing Neurobasal media (Gibco-Invitrogen), B27 neural supplement (Gibco-Invitrogen), 2 mM l-glutamine (Sigma-Aldrich), 100 μg/mL penicillin-streptomycin (Sigma-Aldrich), 20 ng/ mL epidermal growth factor (recombinant human EGF; Gibco-Invitrogen), 20 ng/mL basic fi broblast growth factor (recombinant human bFGF; Gibco-Invitrogen), and 2 ng/mL heparin (Sigma-Aldrich) for 16-18 h at 37°C to enhance cell attachment and survival prior to treatment with dbcAMP and IFN-γ. The optimal concentrations of dbcAMP and IFN-γ were determined by a dose response experiment in which cells were treated with different concentrations of dbcAMP (1 mM, 2 mM, and 4 mM) or IFN-γ (10 ng/mL, 50 ng/mL, 100 ng/mL, and 150 ng/mL). It was found that 4 mM dbcAMP and 100 ng/mL IFN-γ were the optimal concentrations to generate the maximum number of neurons and thus were utilized throughout the course of this study. The cells grown on glass coverslips were used for immunocytochemical studies whereas the cells grown on multiwell or 35-mm tissue culture plates were used for qRT-PCR, cell proliferation, and functional analysis.
Immunocytochemistry
For immunocytochemistry procedures, NSPCs were fi xed in 4% paraformaldehyde for 20 min at 5 or 7 days post-treatment. The control NSPC cultures were seeded for 8-12 h in complete media with mitogens on PDL/laminincoated glass coverslips to allow the cells to adhere prior to fi xation. Cells were blocked in PBS containing 1.5% bovine serum albumin (BSA) and 0.5% Triton X-100 and then incubated for 2 h at room temperature with appropriate primary antibodies including anti-β-tubulin (anti-β-III tubulin; 1:1,000, Abcam, Cambridge, MA) for neurons; anti-glial fi brillary acidic protein (GFAP; 1:100, Chemicon, Temecula, ON, Canada) for astrocytes; anti-RIP (1:5; DSHB, University of Iowa, Iowa City) for oligodendrocytes; anti-Ki67 (1:100; Novocastra Laboratories Ltd., Newcastle upon Tyne, UK) for proliferating cells; and anti-nestin (1:100; BD Biosciences, Mississauga, ON, Canada) for neural precursors.
After 3 10-min PBS washes, the cells were incubated with species-specifi c secondary antibodies conjugated with Indocarbocyanine (Cy3) (Jackson ImmunoResearch Laboratory, Inc., West Grove, PA) for 1 h at room temperature. The glass coverslips were counterstained with the nuclear dye 4′,6-diamidino-2-phenylindole (DAPI) present in vectashield mounting media (Vector Laboratories, Burlingame, CA) and mounted onto microscope slides. Cells were examined and photographed using an Olympus BX61 even neuronal precursors [13] [14] [15] [16] [17] [18] . This fact has been reaffi rmed by our in vivo studies where transplanted NSPCs failed to generate neurons [19, 20] . However, since traumatic SCI results in death of neurons as well as glial cells in and around the lesion site and the disruption of neuronal circuitry and neurological dysfunction, the generation of neurons and reconnection with existing circuitry are essential for functional restoration. In the absence of spontaneous neurogenesis, 1 or more exogenous cues may be required to direct transplanted NSPCs down the neuronal pathway.
In the present study, candidate molecules were selected for preliminary screens that had been previously implicated in neuronal differentiation and included brain-derived neurotrophic factor (BDNF), dibutyryl cyclic AMP (dbcAMP), interferon-gamma (IFN-γ), nerve growth factor (NGF), neurotrophin-3 (NT3), sonic hedgehog (Shh), retinoic acid (RA), and 1% fetal bovine serum (FBS) as a control. BDNF, NGF, and NT3 are members of the neurotrophin (NT) gene family that promote the differentiation and/or survival of neurons [21, 22] . BDNF promotes neuronal differentiation and maturation of adult neural progenitors in vitro [10, 21, 23, 24] . NGF and NT3 also induce neuronal differentiation of NSPCs in vitro, although NT3 works at an early stage of neuronal differentiation [25, 26] . IFN-γ is a cytokine with pleiotropic effects and has been shown to play an important role in regulating the differentiation of neurons from progenitor cells [27] [28] [29] . Shh is a member of the family of hedgehog proteins known to exert important regulatory functions during the patterning and growth of several tissues during development and has been implicated in the regulation of proliferation as well as differentiation of progenitors in the mammalian brain [30, 31] . The effi ciency of 2 small molecules, dbcAMP and RA, to promote neuronal differentiation of NSPCs relative to growth factor/cytokine proteins was evaluated. dbcAMP, a membrane permeable analog of cAMP, has been shown to stimulate neuronal differentiation of HiB5 hippocampal progenitor cells [32] and fetal rat striatal NSPCs [33] . Retinoic acid, a master regulator in regenerating and developing tissue, has been previously implicated in the regulation of neurogenesis in adult NSPC cultures [24] .
These factors were tested for NSPC differentiation to neurons relative to baseline levels attained with 1% FBS controls by immunocytochemistry. Based on initial screens, dbcAMP and IFN-γ were selected for further investigation as potent inducers of neurogenesis of adult NSPCs. These molecules were used alone and in combination to promote neuronal differentiation of these progenitors and characterized using qRT-PCR and immunocytochemistry. To gain greater insight into the functionality of the NSPC-derived neurons, they were characterized further in terms of electrophysiological activity. To our knowledge, this is the fi rst study to demonstrate the combined effects of dbcAMP and IFN-γ on neuronal induction of NSPC progeny by gene expression, protein expression, and electrophysiological activity.
Materials and Methods

Isolation and in vitro differentiation of neural stem/progenitor cells
NSPCs were isolated from the subventricular zone of the lateral ventricles of the forebrains of adult-enhanced green fl uorescent protein (GFP) transgenic male Wistar dye upon binding to dsDNA. The relative fl uorescence units measured correlate with the number of cells present. Cells were seeded at 35,000 cells/cm 2 in 24-well plates for 16-18 h. These adherent cells were then lysed either immediately or after 7 days postdifferentiation by 2 freeze-thaw cycles in 0.5 mL of DNA-free deionized H 2 O frozen at 80°C overnight. DNA samples were then incubated with PicoGreen reagent for 5 min at room temperature, protected from light. Fluorescence of the sample mixtures was measured at excitation and emission wavelengths of 480 and 520 nm, respectively. Each analysis was performed in quadruplicate, and each experiment was repeated 3 times. Calf thymus DNA (Invitrogen) and DNA from 10-fold serial dilutions of known numbers of NSPCs was used to create standard curves for fl uorescent quantifi cation.
Electrophysiology
The extracellular solution was composed of 140 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 25 mM N-2-hydroxyethylpiperazine-N′-thanesulfonic acid (HEPES), 33 mM glucose, and 5.4 mM KCl with pH of 7.3-7.4 and osmolarity ranging from 320 to 330 mOsm. No tetrodotoxin was added to bathing solutions. Recordings were done at room temperature. The membrane potential was held at −60 mV throughout the recordings. Input resistance was monitored by applying a voltage step of −5 mV. The intracellular solution consisted of 140 mM CsF, 11 mM ethyleneglycol-bis-(aminoethyl ether)-N,N′-tetraacetic acid (EGTA) as intracellular calcium chelating buffer, 10 mM HEPES, 2 mM MgCl 2 , 2 mM tetraethyl ammonium chloride (TEA-Cl), 1 mM CaCl 2 , and 4 mM K 2 ATP. Pipette resistance range was 2-4 MΩ. Glutamate-or GABAsensitive currents were evoked by rapid application of 0.5 mM glutamate (or 0.5 mM GABA) solution delivered from a multi-barreled fast perfusion system for 5 s in every min. The solution was delivered at a rate of ~1 mL/min. Wholecell currents were recorded using an Axopatch-1D amplifi er (Molecular Devices, Sunnyvale, CA). Electrophysiological data was digitized with DIGIDATA 1332A and acquired by pClamp8.2 and analyzed by Clampfi t9.2.
Statistical analysis
One-way analysis of variance (ANOVA) followed by the Tukey post-hoc test multiple group comparison was used to identify statistical differences among 3 or more treatments. P < 0.05 (*), P < 0.005 (**), and P < 0.001 (***) were used to indicate levels of statistical signifi cance. The solid lines in the fi gures are used to depict signifi cant differences between 2 groups.
Results
In vitro characterization of adult rat forebrain-derived NSPCs
The adult GFP rat forebrain-derived NSPCs (Fig. 1A) were tested for self-renewal and multipotentiality. To demonstrate self-renewal, NSPCs were seeded on PDL/laminincoated tissue culture slides in the presence of EGF/bFGF/ heparin (EFH) for 8-12 h to promote cell attachment prior to fi xation. The large percentage of undifferentiated cells were proliferative (Fig. 1B) as demonstrated by 56 ± 3.2% of cells epifl uorescent microscope. Semiquantitative immunocytochemistry was performed by examining a minimum of 200 cells per well in fi ve randomly selected fi elds using DAPI to label individual cells. Each analysis was performed in triplicate, and each experiment was repeated 3 times.
Quantitative real-time RT-PCR
Total RNA was isolated using the RNAqueous micro kit (Ambion, Austin, TX) and reverse transcribed by Affi nityScript Multi Temperature cDNA Synthesis Kit (Stratagene, La Jolla, CA) according to the manufacturer's protocol. After cDNA synthesis, qRT-PCR amplifi cation was performed for hypoxanthine phosphoribosyltransferase (HPRT) as a housekeeping gene and β-III tubulin, neuronspecifi c enolase (NSE), 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) and glial fi brillary acidic protein (GFAP), glutamate receptor ionotropic AMPA3 (Grai3), glutamate receptor ionotropic AMPA4 (Grai4) using a LightCycler® 480 PCR Instrument (Roche Applied Science, Laval, QC, Canada). SYBR Green I detection chemistry was used. The 5′ to 3′ sequences for primers and reverse primers were designed from rat mRNA sequences from the National Center for Biotechnology Information (NCBI): for HPRT, the oligonucleotides used were CTCATGGACTGATTATGGACAGGAC (sense primer) and GCAGGTCAGCAAAGAACTTATAGCC (antisense primer); for β-III tubulin, ACTTTATCTTCGGTCA GAGTG (sense primer) and CTCACGACATCCAGGACTGA (antisense primer); for NSE, GAACTATCCTGTGGTCTCC (sense primer) and CGACATTGGCTGTGAACTTG (antisense primer); for CNPase, CAACAGGATGTGGTGAGGA (sense primer) and CTGTCTTGGGTGTCACAAAG (antisense primer); for GFAP, GAGAGAGATTCGCACTCAGTA (sense primer) and TGAGGTCTGCAAACTTGGAC (antisense primer); for Gria3, GGAAATCTGGATTCCAAAGG (sense primer) and TACAGGCGTTCCTAATGCTG (antisense primer); for Gria4, CAAGGGACGCAGACACTAAG (sense primer) and TCCTCTCGAACCAATGTGAT (antisense primer). For qRT-PCR analysis of each sample, the following were prepared in a 12-μL reaction buffer: 2 μL of DNA sample, 6 μL of LightCycler® 480 SYBR Green I Master Mix (2X; Roche Applied Science), 300-400 nM of each forward and reverse primer, and PCR grade water. The real-time analysis involved a 5-min activation step at 95°C, followed by 50 cycles of 10 s at 95°C, 15 s at 60°C, 10 s at 72°C, and a fl uorescence measurement. All qRT-PCR were performed in triplicate. The expression for each target gene was compared to controls (1% FBS), and relative fold change was calculated by normalizing against HPRT gene expression according to the Pfaffl method for relative quantifi cation [34] , following the equation:
PicoGreen dsDNA reagent for measuring cell viability
The effects of different exogenous factors on NSPC viability were compared quantitatively by PicoGreen dsDNA reagent (Molecular Probes-Invitrogen), a live-cell nucleic acid stain. PicoGreen provides a stable measurement parameter by quantifying dsDNA that was present in live cells. The measurement is based on fl uorescence enhancement of the displayed multilineage differentiation upon withdrawal of the mitogens and addition of 1% FBS, providing a differentiation level against which other factors were compared.
Preliminary screening of exogenous factors for neuronal differentiation of NSPCs in vitro
To determine the effects of different exogenous factors on NSPC neurogenesis, neurospheres were dissociated into a single cell suspension and grown in the presence of 1 of the following: BDNF, dbcAMP, IFN-γ, NGF, NT3, Shh, RA, or 1% FBS as a control. After 5 days in culture, β-III tubulin expression was quantitatively evaluated by immunocytochemistry (Fig. 2) . β-III Tubulin is a good marker for neurons as it is expressed in both mature and immature neurons (including cells committed to a neuronal fate that are just postmitotic) [37] [38] [39] . Of all the different factors tested, dbcAMP and IFN-γ promoted the greatest neuronal differentiation of 28.2 ± 1.4% and 41.45 ± 3%, respectively, and signifi cantly more (P < 0.001) than the 1% FBS controls (11.72 ± 0.8%). Amongst the remaining factors (% β-III tubulin-positive cells with BDNF = 19.07 ± 2.49%; NGF = 7.0 ± 4.7%; NT3 = 8.23 ± 4.6%; RA =9.2 ± 1.5%; Shh = 13.9 ± 3.9%), BDNF was the only one that showed a signifi cant enhancement of β-III tubulin-positive cells (P < 0.05) compared to the 1% FBS.
Effects of dbcAMP and IFN-γ, alone and in combination, on neuronal differentiation of NSPCs in vitro
Preliminary screens identifi ed dbcAMP and IFN-γ as target molecules that induce robust neuronal differentiation of NSPCs. The effects of these 2 factors on NSPC neurogenesis, alone and in combination, were determined based on changes in cellular morphology (qualitative) and neuronal expressing Ki67, a prototypic cell cycle-related nuclear protein expressed by cells in all phases of the active cell cycle (G1, S, G2, and M phases) [35] . The vast majority (95.9 ± 2.1%) of the undifferentiated NSPCs were nestin-positive (Fig.  1C) , an intermediate fi lament protein specifi cally found in neuroepithelial precursors [36] while very few cells stained positive for differentiation markers: β-III tubulin (for neurons) = 0%; GFAP (for astrocytes) = 0%; and RIP (for oligodendrocytes) = 0.2 ± 0.01%. To test for multipotentiality, neurospheres were dissociated into a single cell suspension and seeded in EGF and bFGF containing complete media for 8-12 h prior to treatment with 1% FBS for 7 days. These NSPCs differentiated into 1 of the 3 phenotypes (Fig. 1D-F) ; neurons (22.3 ± 1.3%; Fig. 1D ), astrocytes (8.6 ± 2.3%; Fig.  1E ), and oligodendrocytes (40.6 ± 4.4%; Fig. 1F) . A subset of NSPCs continued to express nestin (23.1 ± 3.4%; Fig. 1G ) and a small percentage continued to proliferate (Ki67-positive, 6.7 ± 2.7%; Fig. 1H ). Hence, adult rat NSPCs were highly proliferative in the presence of EGF and bFGF as mitogens and IFN-γ) showed the most signifi cant enhancement of neuronal differentiation over 1% FBS controls, with the latter 2 being the most effective. The solid lines depict signifi cant differences between 2 groups (BDNF vs. 1% FBS, *P < 0.05; dbcAMP vs. 1% FBS, ***P < 0.001; IFN-γ vs. 1% FBS, ***P < 0.001).
subpopulation of cells to differentiate into oligodendrocytes (6.1 ± 0.9% RIP positive cells) and astrocytes (0.40 ± 0.03% GFAP-positive cells). Similarly, the 2 factors in combination produced oligodendrocytes (20.5 ± 3.3% RIP-positive cells), as the primary non-neuronal population, and a small percentage of astrocytes (1.9 ± 0.2% GFAP-positive cells). In contrast, after 7 days of 1% FBS treatment, the majority of cells differentiated into oligodendrocytes (40.6 ± 4.4% RIPpositive cells) and some astrocytes (8.6 ± 2.3% GFAP-positive cells) with 22.3 ± 1.3% neurons (β-III tubulin-positive cells).
Effects of dbcAMP and IFN-γ, alone and in combination, on gene expression profi les of NSPCs in vitro
Quantitative RT-PCR was used to determine the level of neural gene expression of the differentiated NSPCs after treatment with either 1 or both dbcAMP and IFN-γ for β-III tubulin and NSE (both neuronal markers), CNPase (oligodendrocyte marker), and GFAP (astrocyte marker). To facilitate comparison between the different groups, data were normalized relative to the 1% FBS controls. NSPCs cultured in the presence of dbcAMP showed a 2-fold increase in β-III tubulin expression levels over the 1% FBS controls while NSPCs cultured in IFN-γ showed a 3-fold increase and those cultured in both dbcAMP and IFN-γ showed a 5.6-fold increase (Fig. 4A) . Additionally, β-III tubulin mRNA levels in the combination group was signifi cantly greater than that of marker expression (quantitative) (Fig. 3A-E) . In contrast to the preliminary screening (described earlier), NSPCs were "primed" in EGF and bFGF containing complete media to enhance cell attachment and survival, prior to treatment with differentiation factors. Quantitative immunocytochemistry (based on β-III tubulin marker expression) showed that neuronal induction of NSPCs with dbcAMP (58.5 ± 4.3%) was lower than that of IFN-γ treatment (70.9 ± 1.7%), after 7 days in culture (Fig. 3A and B) . However, dbcAMP-differentiated cells grew longer neurites than their IFN-γ counterparts (Fig.  3A and B) . Importantly, the combined treatment of NSPCs with dbcAMP and IFN-γ enhanced neuronal differentiation and resulted in greater β-III tubulin expression (82.4 ± 2.9%) and morphological differentiation (longer neurites and network formation) compared to either factors alone (P < 0.001 for dbcAMP, P < 0.05 for IFN-γ; Fig. 3A-C) . In contrast, the 1% FBS control showed baseline differentiation of NSPCs into neurons of 22.3 ± 1.3% (β-III tubulin-positive cells) and was signifi cantly lower than the other treatments (P < 0.001; Fig. 3D) .
Additionally, the individual and combined effects of dbcAMP and IFN-γ on astroglial (GFAP) and oligodendrocyte (RIP) differentiation of NSPCs were evaluated (Fig.  3E) . dbcAMP enhanced oligodendrocyte differentiation (32.8 ± 2.6% RIP-positive cells) compared to IFN-γ alone and a combination of dbcAMP and IFN-γ (P < 0.001, P < 0.05), with negligible production of astrocytes (0.02 ± 0.1% GFAP-positive cells). In contrast, IFN-γ directed a small A-D) . Quantitative analysis of neural marker expression (β-III tubulin, anti-glial fi brillary acidic protein (GFAP), RIP) by differentiated NSPCs (mean ± SD; n = 9) showed a signifi cantly higher percentage of β-III tubulin-positive cells in the combined treatment compared to either factor alone (the solid lines depict signifi cant differences between 2 groups; dbcAMP + IFN-γ vs. dbcAMP, ***P < 0.001; dbcAMP + IFN-γ vs. IFN-γ, *P < 0.05), while all treatment groups showed greater neuronal differentiation compared to the 1% FBS controls (all treatment groups vs. 1% FBS, ***P < 0.001). In contrast, the 3 treatment groups produced negligible number of astrocytes while dbcAMP generated signifi cantly higher numbers of oligodendrocytes compared to IFN-γ alone or in combination (dbcAMP vs. IFN-γ, ***P < 0.001; dbcAMP vs. dbcAMP + IFN-γ, *P < 0.05) (E).
dsDNA from each treatment group was quantifi ed using the PicoGreen assay (Fig. 5) . In the present study, NSPCs grown overnight in the presence of complete media correspond to the 0 day time point (number of viable cells = 27,000 ± 5,300) and are represented by the dotted line in Figure 5 . After 7 days in culture, the number of cells in the dbcAMP (31,800 ± 3,700) and combination (23,700 ± 2,200) groups did not show an increase over the 0 day time point (P > 0.05). However, both the IFN-γ (45,800 ± 900) and 1% FBS control (64,200 ± 3,700) groups showed a signifi cant enhancement in cell numbers compared to the starting 0 day cell population (P < 0.001).
Electrophysiology of dbcAMP-and/or IFN-γ-differentiated NSPCs
To confi rm that NSPCs have the potential to differentiate into functional neuronal cells, whole-cell patch-clamp recordings were made from dissociated cells attached NSPCs cultured in dbcAMP (P < 0.001) or IFN-γ (P < 0.05) alone. In contrast, a 4-fold (P < 0.001) and 2-fold (P < 0.001) increase in NSE expression were observed in dbcAMP-and combination-treated groups, while there was no significant difference in the amounts of NSE transcripts in IFN-γ-treated cells compared to the 1% FBS controls (P > 0.05; Fig.  4B ). In addition to the neuronal transcripts, oligodendrocyte and astrocyte mRNA levels were also assayed. NSPCs cultured in the presence of dbcAMP expressed 0.5-fold levels of CNPase mRNA relative to the control (P < 0.001), while the IFN-γ and combination groups showed even lower levels of CNPase transcripts (P < 0.001; Fig. 4C ). GFAP transcripts were expressed at signifi cantly lower levels in the 3 treatment groups compared to the 1% FBS control (P < 0.001; Fig. 4D ).
Effects of dbcAMP and IFN-γ on NSPC viability
To gain greater insight into the effects of different exogenous treatments on NSPC viability, the total amount of qRT-PCR results showed that NSPCs treated with the combination of dbcAMP and IFN-γ showed signifi cantly higher expression of β-III tubulin than those treated with either dbcAMP (***P < 0.001) or IFN-γ (**P < 0.05). However, dbcAMP-treated NSPCs resulted in signifi cantly greater expression of NSE (mature neuronal marker) and CNPase (oligodendrocyte marker) compared to IFN-γ alone or in combination (dbcAMP vs. other treatments, ***P < 0.001). The 3 treatment groups generated negligible number of GFAPpositive astrocytes. The solid lines depict signifi cant differences between different groups.
Previously, dbcAMP alone or in combination with other factors, such as bFGF and NGF, has been shown to induce in vitro neuronal differentiation from fetal rat striatal NSPCs [33] and several different cell lines including human neuroblastoma (NB69) [40] , rat neuroblastoma and mouse glioma hybridoma (NG108-15 cells) [41] , rat pheochromocytoma (PC12) [42] , and embryonal carcinoma cells (P19S18O1A1) [43] . In the present study, dbcAMP treatment of NSPCs resulted primarily in neuronal differentiation as assayed by β-III tubulin expression and morphological differentiation. Additionally, NSE gene expression profi les suggest that most of the neurons generated by dbcAMP were mature [44] . Apart from the neuronal progeny, a signifi cant number of oligodendrocytes were also generated in response to dbcAMP, suggesting that it is a pleiotropic factor with more than 1 potential target in the NSPC population.
Similarly, IFN-γ has been shown to promote neuronal differentiation of adult mouse/rat neural progenitor cells and C17.2 NPC line [27] [28] [29] . Our results reveal a similar fi nding whereby IFN-γ resulted primarily in neuronal differentiation, as assayed by β-III tubulin expression, while very few cells differentiated into oligodendrocytes and a negligible number into astrocytes. The neurons generated in response to IFN-γ were morphologically distinct from those derived from either dbcAMP or dbcAMP and IFN-γ together-that is, they had shorter neurites. The relatively low NSE mRNA levels suggest that a majority of the neurons derived from NSPCs with IFN-γ stimulation were less mature than those present in the dbcAMP and combination groups [44] .
Our electrophysiological results also suggest that IFN-γ may give rise to a different neuronal subtype than either dbcAMP and/or the combination of dbcAMP and IFN-γ. The transient currents observed in the differentiated NSPCs in the 3 treatment groups may be a result of kainate receptors since kainate currents desensitize very rapidly. Some of the relatively larger currents (Fig. 6 ) observed in IFN-γ-stimulated cells generated a transient response plus a sustained response upon stimulation with glutamate. These currents could be conducted by both kainate receptors (transient part) and AMPA receptors (sustained part). Overall transient responses were observed more often than the sustained responses in the 3 stimulatory conditions, suggesting that kainate receptors are expressed earlier than AMPA receptors. The expression of AMPA receptor subunits, Grai3 to PDL/laminin-coated tissue culture plates and treated with dbcAMP and IFN-γ for 7 days, alone or in combination (Fig. 6) . Glutamate (0.5 mM) and γ-aminobutyric acid (GABA, 0.5 mM) were applied to test for the presence of neurotransmitter receptors in differentiated NSPCs. The neuronal progeny from the 3 treatment groups exhibited a differential response to the glutamate stimulus that was completely blocked by CNQX (40 μM), an AMPA/kainate receptor antagonist. However, none of the tested cells responded to the GABA challenge. The mean current amplitude (pA) of dbcAMP-treated NSPCs that were responsive to glutamate was small (23.3 ± 6.8 pA; n = 8 out of 12) compared to the combination where the current was larger but transient (78.3 ± 59.1 pA; n = 6 out of 12). In comparison, IFN-γ-differentiated progeny constituted 2 different cell types, one with a small transient current (41 ± 13 pA; n = 5 out of 12), while the other exhibited both transient and sustained currents (180 ± 116 pA; 60 ± 47 pA; n = 7 out of 12).
Discussion
In vitro-expanded NSPCs from the adult forebrain may be used for neuronal cell replacement. However, it has not been easy to fi nd factors that reliably produce differentiated neurons in signifi cant numbers. In the present in vitro study, we screened a number of growth factors and small molecules to elucidate their effects on NSPC neurogenesis. These included a selection of molecules such as BDNF, dbcAMP, IFN-γ, NGF, NT3, Shh, and RA that have previously been shown to play a major role in survival and/or differentiation of neurons [10, 21, [23] [24] [25] [26] [27] [28] [30] [31] [32] . The rationale behind these screenings was that although these factors had been previously shown to promote neurogenesis, their neuronal potential is inconsistent across species (mouse, rat, human), cell type (adult versus embryonic CNS-derived stem cells; SVZ versus hippocampal; stem/progenitor cells versus primary cultures/cell lines), and even number of passages in vitro. The results of our preliminary screenings showed that dbcAMP and IFN-γ were the most effective in inducing neuronal differentiation of adult NSPCs. Hence, these factors were selected for further investigation and a detailed analysis of their individual and combined effects on NSPC neurogenesis was carried out during the course of this study. time, the combined effect of dbcAMP and IFN-γ on neuronal induction of rat NSPC progeny. Data from this study shows that these factors work together to enhance neuronal differentiation based on β-III tubulin expression and morphological differentiation (longer neurites and network formation). The synergistic effects of dbcAMP and IFN-γ on neuronal differentiation were also verifi ed across species on adult mouse SVZ-derived NSPCs (Supplementary Fig. 2 ). It is likely that the synergistic effects of these 2 molecules on neuronal differentiation involve both c-jun N-terminal kinase (JNK) and mitogen-activated protein kinase (MAPK)/ extracellular signal-regulated kinase (ERK) signaling pathways that have been shown to be involved in the neuronal induction by dbcAMP or IFN-γ [28, 33, 41] . The combined results of qRT-PCR (based on relative β-III tubulin transcript expression), electrophysiological, and morphological analysis of the neuronal progeny generated by the combined dbcAMP and IFN-γ treatment of NSPCs suggest that there is and Grai4, by NSPCs treated with dbcAMP and/or IFN-γ was confi rmed using qRT-PCR (Supplementary Fig. 1 ; Supplementary materials are available online at http:// www.liebertpub.com). Gene expression levels were normalized against endogenous levels of HPRT. NSPCs treated with IFN-γ showed a 2-to 2.5-fold difference in Grai3 and Grai4 transcript levels, respectively, compared to dbcAMP and the combination (IFN-γ vs. other treatments, ***P < 0.001). The qRT-PCR data corroborate the results of our electrophysiological studies. This study suggests that dbcAMP and IFN-γ-treated cells may develop some basic neuronal membrane properties. However, long-term induction and co-culture with other neural cell types may be required to generate functionally mature neurons.
Although individually dbcAMP and IFN-γ have previously been implicated in neuronal differentiation, the combined effects of dbcAMP and IFN-γ on NSPC differentiation have not been studied. The present study shows, for the fi rst Whole-cell currents evoked by 0.5 mM glutamate in NSPC-differentiated neuronal progeny were recorded. The mean current amplitude (pA) of dbcAMP-treated NSPCs was small compared to the combination where the current was larger but transient. In comparison, IFN-γ-differentiated cells constituted 2 different subtypes, one with a small transient current, while the other exhibited both transient and sustained currents. These currents were successfully blocked by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (40 μM).
substantial enhancement in neuronal differentiation and the resulting neurons are quite distinct from the dbcAMP and IFN-γ counterparts.
We also examined the effects of these exogenous factors on NSPC proliferation. Treatment of NSPCs with dbcAMP alone or in combination with IFN-γ resulted in very low levels of NSPC proliferation. Hence, it appears that the in vitro differentiation of NSPCs in response to dbcAMP is not due to a proliferative effect but instead, the differentiation profi le could be the result of selective survival and subsequent differentiation or cell death of specifi c progenitor pools. Our results are consistent with past fi ndings where neuronal induction of hippocampal progenitor cells was accompanied by an inhibition of proliferation [32] . In contrast to the dbcAMP treatment, the signifi cant increase in number of viable cells that was observed with IFN-γ suggests that this factor may promote the formation of neurons, by selecting for and enhancing the neuronal progenitor pool. However, our results contrast with previous fi ndings where IFN-γ has been shown to inhibit NSPC proliferation in a dose-dependent manner [27, 28] . Several factors may account for the contrasting results including species differencesmouse versus rat-and NSPCs plated onto PDL/laminincoated tissue culture plates versus uncoated tissue culture fl asks [27] .
The long-term goal of the present study was to identify a potent combination of growth factors and small molecules to induce maximal neuronal differentiation of rat NSPCs. Having identifi ed this novel combination of dbcAMP and IFN-γ for in vitro generation of neurons, we are currently incorporating these factors into drug delivery systems for localized and sustained in vivo release, for directing neuronal cell fate of transplanted cells in a rat model of SCI.
